Abstract
Objective and methodManagement of latent tuberculosis infection (LTBI) is one of the core elements of End TB Strategy. Japan is one of the few countries in which notification of LTBI is mandatory, yet so far, the data has not been analyzed in detail. We thus conducted a cross-sectional study to examine the trend of LTBI, its treatment outcome and factors predicting treatment non-completion in Japan for the period of 2007 and 2014, using the data from the electronic Japan Tuberculosis Surveillance system. Treatment completion was defined as those whose reason for terminating the treatment was recorded as “treatment completed” and whose treatment duration was 180 days or more.ResultsDuring the study period, a total of 50,268 LTBI patients were notified, of which 49,525, who had started treatment, were analyzed for characteristics. 57.5% were females, and 38.5% were aged 25–44 years. As for the job category, healthcare professionals, that is medical doctors, nurses and other healthcare workers, consisted the largest group (30.4%). Overall, the number of LTBI notification has been on an increase, with a large increase observed among those aged 65 years and above. Of the 49,525 patients, the information regarding reason for termination of treatment was available for 46,128 (93.1%). Of them, 33,156 (71.9%) had completed treatment as according to the study definition. The risk factors for not completing LTBI treatment included being aged 65 years and above (adjusted odds ratio [aOR] 1.27, 95% confidence interval [95%CI] 1.10–1.47), foreign-born (aOR 1.14, 95%CI 1.02–1.28), healthcare professional (aOR 1.44, 95%CI 1.24–1.69), full-time and part-time worker (aOR 1.40, 95%CI, 1.20–1.63) and detected via contact investigation (aOR 1.26, 95%CI 1.12–1.41).ConclusionsOur study results revealed that the treatment completion rate was 71.9%, falling short of the national target of 85%, and also that the treatment duration was recorded as less than 180 days for approximately 20% of those who were reported as having completed treatment. Further studies may be built on ours to explore the reasons for not completing the treatment across different population groups, and identify those who benefit the most, and who has the greatest impact on ending TB, by receiving LTBI treatment.
Highlights
It has been estimated that one third of the world’s population is infected with M.tuberculosis [1]
Further studies may be built on ours to explore the reasons for not completing the treatment across different population groups, and identify those who benefit the most, and who has the greatest impact on ending TB, by receiving latent tuberculosis infection (LTBI) treatment
Between 2007 and 2014, a cumulative total of 50,268 LTBI patients were notified to the Japan TB Surveillance system (JTBS), of which 743 (1.5%) either did not initiate treatment or whose treatment status was unknown upon notification
Summary
It has been estimated that one third of the world’s population is infected with M.tuberculosis [1]. In 2015, the World Health Organization (WHO) published a guideline on management of latent tuberculosis infection (LTBI), largely targeted at high- and upper middle-income countries with an estimated tuberculosis (TB) incidence rate of less than 100 per 100,000, in which it recommended active and systematic identification and treatment of people with LTBI for certain high–risk populations [2]. The overall trend in the notification of LTBI has been reported annually, its details and especially the treatment status are and have remained unanalyzed. The electronic Japan TB Surveillance system (JTBS) only has an algorithm to determine the treatment outcome of pulmonary TB at the end of 12 months. We attempted a detailed analysis of LTBI notifications and on the status of treatment, using the available data from the JTBS
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
